RECRUITING

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.

Official Title

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy: a Randomized Controlled Trial

Quick Facts

Study Start:2024-11
Study Completion:2025-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06653400

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients assigned female at birth,
  2. * booked for office hysteroscopy at Mount Sinai Hospital faculty practice associates.
  1. * Allergy to ketorolac or non-steroidal anti-inflammatory medications
  2. * Allergy to lidocaine
  3. * Presence of thrombocytopenia
  4. * Contraindications to lidocaine
  5. * History of gastritis or gastric ulcer
  6. * Acute renal failure or chronic renal disease
  7. * Chronic liver disease
  8. * History of bleeding diathesis
  9. * Long term narcotic use

Contacts and Locations

Study Contact

Kathleen E Ackert, DO
CONTACT
212-241-4500
kathleen.ackert@mssm.edu
Virginia H Flatow, MD
CONTACT
virginia.flatow@mssm.edu

Principal Investigator

Charles Ascher-Walsh, MD
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai

Study Locations (Sites)

Mount Sinai
New York, New York, 10029
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Charles Ascher-Walsh, MD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11
Study Completion Date2025-09-01

Study Record Updates

Study Start Date2024-11
Study Completion Date2025-09-01

Terms related to this study

Additional Relevant MeSH Terms

  • Abnormal Uterine Bleeding
  • Analgesia
  • Paracervical Block